SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001104659-22-078077
Filing Date
2022-07-07
Accepted
2022-07-07 16:45:56
Documents
10

Document Format Files

Seq Description Document Type Size
1 F-1 tm2220308-1_f1.htm F-1 720158
2 EXHIBIT 5.1 tm2220308d2_ex5-1.htm EX-5.1 29922
3 EXHIBIT 8.1 tm2220308d2_ex8-1.htm EX-8.1 20846
4 EXHIBIT 23.1 tm2220308d2_ex23-1.htm EX-23.1 2176
5 EX-FILING FEES tm2220308d2_ex-filingfees.htm EX-FILING FEES 37458
6 GRAPHIC lg_evaxion-4c.jpg GRAPHIC 28099
7 GRAPHIC tm2220308d2_ex5-1img01.jpg GRAPHIC 2877
8 GRAPHIC tm2220308d2_ex5-1img02.jpg GRAPHIC 780
9 GRAPHIC tm2220308d2_ex8-1img001.jpg GRAPHIC 2863
10 GRAPHIC tm2220308d2_ex8-1img002.jpg GRAPHIC 778
  Complete submission text file 0001104659-22-078077.txt   861053
Mailing Address BREDGADE 34E COPENHAGEN K G7 1260
Business Address BREDGADE 34E COPENHAGEN K G7 1260 4531262615
Evaxion Biotech A/S (Filer) CIK: 0001828253 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-266050 | Film No.: 221072094
SIC: 2836 Biological Products, (No Diagnostic Substances)